Sleep breathing disorders are a family of conditions in which normal breathing repeatedly stalls, slows, or becomes labored during sleep, fragmenting rest and starving the body of oxygen. The most common is obstructive sleep apnea, where the throat physically collapses, but the spectrum also includes central sleep apnea, in which the brain temporarily stops sending the signal to breathe, and subtler forms like upper airway resistance syndrome. These conditions collectively affect hundreds of millions of people worldwide, and their consequences reach well beyond poor sleep, driving up the risk of high blood pressure, heart disease, metabolic problems, and cognitive decline.
How the Airway Collapses in Obstructive Sleep Apnea
During waking hours, muscles in and around the throat actively hold the airway open. When you fall asleep, that muscle tone drops. In most people, the airway stays open enough that breathing continues without trouble. In obstructive sleep apnea (OSA), the soft tissues of the throat narrow or close entirely, blocking airflow despite ongoing effort from the chest and diaphragm. After several seconds without air, a brief arousal jolts the brain just enough to restore muscle tone and reopen the airway, usually accompanied by a loud gasp or snort. This cycle can repeat dozens of times per hour.
A systematic review and meta-analysis examining what makes some airways more collapsible than others found that no single anatomical feature is a strong predictor on its own. Four features showed a moderate relationship with airway collapsibility: the position of the hyoid bone (the small horseshoe-shaped bone in the neck), tongue volume, the length of the pharynx, and waist circumference. Neck circumference and body mass had weaker associations, and airway volume and jaw length were weaker still.1PubMed Central. Anatomical determinants of upper airway collapsibility in obstructive sleep apnea: a systematic review and meta-analysis Separate work looking at skeletal and soft-tissue measurements confirmed that both soft-tissue crowding and a low-sitting hyoid bone contribute to airway collapsibility in people with OSA.2American Journal of Respiratory and Critical Care Medicine. Upper Airway Collapsibility and Cephalometric Variables in Patients with Obstructive Sleep Apnea
The takeaway is that anatomy matters, but it is only one piece. Research into what are called “endotypes” shows that not everyone develops sleep apnea for the same reason. In some people, the problem is primarily structural. In others, the brain’s arousal threshold is too low, meaning the person wakes too easily before the airway muscles have a chance to compensate. In still others, the muscles themselves are unusually weak during sleep, or the brain’s respiratory control system overshoots and undershoots. Identifying which combination of factors is driving a particular person’s apnea is increasingly seen as the key to choosing the right treatment.3PubMed Central. Endotypes and phenotypes in obstructive sleep apnea
Central Sleep Apnea and the Brain’s Role
Central sleep apnea (CSA) looks very different from the obstructive kind. Instead of the airway physically closing, the brain simply pauses its command to breathe. There is no chest effort, no blocked airway, just silence. CSA is defined by a lack of respiratory drive during sleep, producing repeated episodes of inadequate ventilation and impaired gas exchange.4PubMed Central. Central sleep apnea: Pathophysiology and treatment
One well-known form of CSA is Cheyne-Stokes respiration, which is particularly common in people with heart failure. In this pattern, breathing gradually crescendos to deep rapid breaths, then decrescendos back to nothing, cycling over and over. The underlying problem is instability in the brain’s carbon-dioxide feedback loop. People with heart failure who develop this pattern tend to be slightly over-ventilated even while awake, meaning their carbon dioxide levels sit closer than normal to the threshold at which the brain stops sending the “breathe” signal. Even a small further dip is enough to trigger an apnea. Factors like congestion in the lungs, heightened sensitivity in chemical sensors, reduced blood flow to the brain, and the frequent arousals themselves all feed the cycle.5PubMed. Central sleep apnea and Cheyne-Stokes respiration
Upper Airway Resistance Syndrome
Between normal breathing and full-blown apnea sits upper airway resistance syndrome (UARS). People with UARS do not stop breathing or experience the dramatic oxygen drops seen in OSA. Instead, the airway narrows just enough to increase the effort needed to pull air through, and that extra effort triggers brief arousals that shatter sleep continuity. The hallmark symptom is excessive daytime sleepiness, driven directly by these repeated micro-awakenings rather than by oxygen deprivation.6PubMed. The upper airway resistance syndrome Diagnosing UARS requires measuring not just airflow but also inspiratory effort, since standard sleep studies that only count apneas and hypopneas can miss it entirely.7PubMed. The symptoms and signs of upper airway resistance syndrome: a link to the functional somatic syndromes
UARS is worth knowing about because it explains a frustrating clinical scenario: the person who is profoundly sleepy, whose sleep study comes back “normal” or borderline, and who gets told nothing is wrong. The condition is underdiagnosed partly because the standard metric used to score sleep apnea severity, the apnea-hypopnea index, was designed to count events that UARS often does not produce.
What Happens to the Body Over Time
The repeated oxygen drops in obstructive sleep apnea, called intermittent hypoxia, set off a cascade of damage that extends far beyond feeling tired. Each dip triggers a burst of sympathetic nervous system activity, the same “fight or flight” response you would get from acute stress. Over months and years, that nightly hammering rewires the system. Research shows that cyclic intermittent hypoxia, rather than the sleep disruption itself, is the primary driver of the sustained high blood pressure seen in OSA. The blood pressure increase is a direct consequence of the chronic sympathetic activation, and it persists during the daytime even after normal oxygen levels have been restored.8PubMed. Sympathoexcitation and arterial hypertension associated with obstructive sleep apnea and cyclic intermittent hypoxia
Animal experiments have traced the mechanism further. Chronic intermittent hypoxia activates the sympathetic nerves that supply the kidneys, which in turn ramps up the renin-angiotensin system (a hormonal pathway that raises blood pressure), promotes sodium retention, increases oxidative stress, and damages the lining of blood vessels. When researchers severed those renal sympathetic nerves in animal models, the harmful effects were largely blocked, pointing to this nerve pathway as a major causal link between sleep apnea and cardiovascular disease.9Scientific Reports. Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease
OSA also compounds the metabolic damage of obesity. In obese people, those with OSA show significantly greater sympathetic activation, inflammation, and blood-vessel dysfunction compared with weight-matched people without OSA, suggesting that apnea is not merely a side effect of excess weight but an independent accelerant of metabolic disease. Intermittent hypoxia worsens insulin resistance and promotes fatty liver disease on top of what obesity alone causes.10PubMed Central. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome
The Brain Under Siege
The cognitive toll of untreated sleep-disordered breathing is increasingly worrying researchers. Emerging evidence links untreated OSA with a higher risk of cognitive decline, vascular dementia, and Alzheimer’s disease.11PubMed Central. Role of Obstructive Sleep Apnea in Cognitive Impairment The proposed pathway involves the same intermittent hypoxia and high blood pressure that damage the heart. Together, these reduce blood flow and energy metabolism in the brain, particularly in the cortex and hippocampus, the region most critical for forming memories. Reviews of the evidence show that OSA promotes hippocampal shrinkage, upregulates the amyloid-beta and tau proteins associated with Alzheimer’s, and disrupts synaptic function. Because OSA is a treatable condition, researchers have flagged it as a potentially modifiable risk factor, meaning that catching and treating it in middle age could reduce the odds of cognitive decline later on.12PubMed. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly
Why Diagnosis Is Trickier Than It Looks
Sleep apnea is typically diagnosed by measuring the apnea-hypopnea index (AHI) during an overnight sleep study, either in a lab or at home. The number represents how many times per hour your breathing stops or significantly decreases. The trouble is that this number can vary substantially from one night to the next in the same person. A study of night-to-night variability during home sleep testing found that the AHI shifted by roughly minus 14 to plus 10 events per hour between nights, enough to bump someone into a different severity category. Based on a single night’s recording, the study estimated that about one in seven people would be overtreated and about one in seventeen undertreated. The biggest predictors of how much the number bounced around were how much time the person spent in deep sleep and how much time they spent sleeping on their back.13PubMed. Determinants of apnea-hypopnea index variability during home sleep testing
For children, the picture is even more complicated. A comparison of portable home monitors against full in-lab sleep studies in children found that the portable device’s sensitivity for catching OSA was about 81% when used in the lab, but dropped to roughly 70% when used at home.14PubMed. Comparison of home sleep apnea testing versus laboratory polysomnography for the diagnosis of obstructive sleep apnea in children That means nearly a third of affected children could get a falsely reassuring result from a single home test. These limitations do not make home testing useless, but they do mean that a single “normal” night does not necessarily rule anything out, especially if symptoms are present.
Treatment Beyond CPAP
Continuous positive airway pressure (CPAP) remains the front-line treatment for moderate-to-severe OSA. It works by blowing a steady stream of pressurized air through a mask to splint the airway open. In people with heart failure and OSA, CPAP has been shown to lower daytime blood pressure by about 10 points, slow the resting heart rate, and improve heart-pumping efficiency, with the left ventricular ejection fraction climbing from roughly 25% to about 34%.15PubMed. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea
But CPAP’s real-world impact hinges on whether people actually use it. The large SAVE trial, which enrolled thousands of patients with established cardiovascular disease and moderate-to-severe OSA, found no reduction in heart attacks, strokes, or cardiovascular death with CPAP compared with usual care over nearly four years. A critical detail: average nightly use was only about 3.3 hours, well below the 6 to 7 hours most people spend in bed.16The New England Journal of Medicine. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea The trial did confirm that CPAP dramatically reduced the AHI (from about 29 to under 4 events per hour), so the device works when it is on. The gap between biological effectiveness and real-world benefit is almost entirely an adherence problem, and it is the reason researchers are so interested in alternatives.
Oral Appliances
Mandibular advancement devices are custom-fitted mouthpieces that push the lower jaw forward, widening the space behind the tongue.17PubMed Central. Mandibular advancement device for obstructive sleep apnea: An overview A randomized trial found that an advancement splint roughly halved the AHI (from about 30 to 14 events per hour) and improved minimum oxygen levels, with about 63% of patients achieving a complete or partial response.18American Journal of Respiratory and Critical Care Medicine. A Randomized, Controlled Study of a Mandibular Advancement Splint for Obstructive Sleep Apnea Clinical guidelines now recommend these devices for mild OSA and for people with more severe disease who cannot tolerate CPAP.19PubMed Central. An update on mandibular advancement devices for the treatment of obstructive sleep apnoea hypopnoea syndrome They are smaller, quieter, and easier to travel with, which helps with consistency, though they can cause jaw soreness and bite changes over time.
Hypoglossal Nerve Stimulation
For people who have failed CPAP and oral appliances, a surgically implanted device that stimulates the hypoglossal nerve (the nerve controlling the tongue) has become a viable option. The device senses breathing effort and delivers a mild electrical pulse to stiffen the tongue and open the airway each time the person inhales during sleep. In one study, the intervention group’s AHI dropped from about 43 to 14 events per hour after implantation, and quality-of-life scores improved substantially.20PubMed Central. Quality of Life Impact of Hypoglossal Nerve Stimulation with Inspire Device in Patients with Obstructive Sleep Apnea Intolerant to Continuous Positive Airway Pressure Therapy The device is not suitable for everyone; candidates typically need moderate-to-severe OSA, must have failed CPAP, and must have a specific pattern of airway collapse that the stimulation can address.
Drug Therapy on the Horizon
Pharmacotherapy for OSA has been a white whale for decades, but a combination approach using a noradrenergic drug (which boosts muscle tone) plus an antimuscarinic drug (which reduces certain secretions and further supports airway stiffness) has shown early promise. A meta-analysis of randomized trials found this combination reduced the AHI by about 11 events per hour relative to placebo and improved minimum oxygen levels, while also lowering the arousal index. The drugs modestly improved airway collapsibility and loop gain, though they also lowered the arousal threshold, which could theoretically be a drawback for some patients.21PubMed. Combined noradrenergic plus antimuscarinic agents for obstructive sleep apnea – A systematic review and meta-analysis of randomized controlled trials The most studied combination is atomoxetine plus oxybutynin, and work continues on refining drug pairings and doses.22PubMed Central. Development of a combination of noradrenergic and antimuscarinic drugs for the treatment of obstructive sleep apnea: Challenges and progress These are not yet standard treatment, but they represent the first credible pharmaceutical path to treating OSA without a device.
Sleep Breathing Disorders in Children
Children are not simply small adults when it comes to sleep apnea. The causes, symptoms, and treatments differ markedly. In children, the most common culprit is enlarged tonsils and adenoids rather than obesity or age-related tissue laxity. Symptoms are often less obvious than in adults: instead of loud snoring and witnessed apneas, parents may notice restless sleep, mouth breathing, bedwetting, or behavioral problems that mimic attention-deficit disorders. Treatment in most children centers on surgically removing the tonsils and adenoids, which is effective in the majority of cases, rather than CPAP.23PubMed. Obstructive Sleep Apnoea: Children are not little Adults Recognizing these differences matters because screening tools and severity scales designed for adults can miss or misclassify childhood OSA.
Pregnancy and Disordered Breathing
Sleep-disordered breathing is common during pregnancy, driven by hormonal changes, weight gain, and the mechanical effects of the growing uterus pushing the diaphragm upward.24PubMed. Obstructive sleep apnea in pregnancy: emerging insights into maternal and fetal outcomes Prevalence rises as pregnancy progresses, and the condition remains widely underdiagnosed in this population. Women at highest risk include those who enter pregnancy with a higher body mass, are older, or have pre-existing high blood pressure.25PubMed Central. Obstructive Sleep Apnea in Pregnancy: A Narrative Review Untreated OSA in pregnancy is increasingly linked to serious complications for both mother and baby, paralleling the cardiovascular and metabolic risks seen in non-pregnant populations but with the added concern for fetal health.26PubMed Central. Obstructive Sleep Apnea in Pregnant Women: A Review of Pregnancy Outcomes and an Approach to Management Screening is challenging because normal pregnancy symptoms, including fatigue, frequent waking, and nasal congestion, overlap heavily with apnea symptoms, making it easy for clinicians and patients alike to dismiss warning signs.
Altitude and Periodic Breathing
You do not need an underlying health condition to develop disordered breathing during sleep. At high altitude, periodic breathing during sleep is almost universal among people who have traveled up from lower elevations.27PubMed. A narrative review of periodic breathing during sleep at high altitude: From acclimatizing lowlanders to adapted highlanders The thin air at altitude triggers the same kind of respiratory-control instability seen in central sleep apnea: the brain overshoots in its effort to compensate for low oxygen, drives carbon dioxide too low, and breathing temporarily stops until COâ‚‚ rises enough to restart the cycle. The result is a pattern of alternating central apneas and brief hyperventilation episodes throughout the night.28PubMed. Altitude-induced central sleep apnea does not affect mean sleep oxygen saturation in young healthy males Trekkers, skiers, and mountaineers often notice they wake repeatedly with a feeling of air hunger on their first nights at elevation. This form of disordered breathing typically improves with acclimatization over several days, and it is generally considered a normal physiological response rather than a disease state, though it can significantly degrade sleep quality during the acclimatization period.
Drowsy Driving and Public Safety
The fragmented sleep caused by breathing disorders translates directly into real-world danger behind the wheel. Sleepiness from untreated apnea slows reaction time and impairs judgment in ways that resemble alcohol intoxication. Commercial drivers are a particular concern: research has shown that sleep apnea among truck and bus drivers increases the risk of fall-asleep crashes, which tend to be high-speed, high-severity events with outsized costs in injuries, fatalities, and property damage.29PubMed Central. Estimated cost of crashes in commercial drivers supports screening and treatment of obstructive sleep apnea Several countries and jurisdictions have implemented or debated mandatory screening of commercial drivers for sleep apnea, though enforcement and compliance vary widely. For non-commercial drivers, the risk is less studied but still real, and it is one of the most immediate, tangible reasons to get treatment rather than simply living with the snoring.